Table 2.
Comparison of methods for probing translation.
| Puromycin reagents | Non-puromycin alternatives | Method of detection | Comments | |
|---|---|---|---|---|
| Translation rate measurement | Radioactive puromycin [35] | Radioactive amino acids (AAs) [55] | Scintillation or autoradiography | AA analogs do not terminate translation, but puromycin can be used without predepletion of endogenous AAs |
| Puromycin/OPP (SUnSET) [8], [22] | Clickable AAs [56] | Immunoblot or FACS | ||
| Visualization of newly synthesized proteins | Puromycin/OPP (RPM, Puro-PLA) [8], [14], [42] | Clickable AAs (FUNCAT, FUNCAT-PLA) [42], [57] | Immunofluorescence | AA analogues do not terminate translation, but only puromycin can be used to label sites of active translation when combined with inhibitors of elongation |
| Translatome analysis | N-blocked biotinylated puromycin (RiboLace) [16] | Deep sequencing of nuclease-resistant ribosome-protected mRNA (ribo-seq) [58] | Next generation sequencing | RiboLace can be used to affinity purify translating ribosomes prior to ribo-seq analysis |
| Biotinylated puromycin/OPP (PUNCH-P/OPP-ID) [44], [47] | AA isotopes (pSILAC) [59] Clickable AAs (BONCAT/QuaNCAT) [56], [60] | Mass spectrometry | AA analogs do not terminate translation, but puromycylation is rapid, AA nonspecific and can occur on isolated ribosomes |